GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Registered Plan Private Investments Inc (OTCPK:LXGTF) » Definitions » YoY EBITDA Growth

Registered Plan Private Investments (Registered Plan Private Investments) YoY EBITDA Growth : -193.88% (As of Dec. 2019)


View and export this data going back to 2017. Start your Free Trial

What is Registered Plan Private Investments YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Registered Plan Private Investments's YoY EBITDA Growth for the quarter that ended in Dec. 2019 was -193.88%.

Registered Plan Private Investments's EBITDA per Share for the three months ended in Dec. 2019 was $-0.14.


Registered Plan Private Investments YoY EBITDA Growth Historical Data

The historical data trend for Registered Plan Private Investments's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Registered Plan Private Investments YoY EBITDA Growth Chart

Registered Plan Private Investments Annual Data
Trend Dec16 Dec17 Dec18 Dec19
YoY EBITDA Growth
- 44.69 8.20 49.67

Registered Plan Private Investments Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71.35 73.68 84.08 82.46 -193.88

Registered Plan Private Investments YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Registered Plan Private Investments's YoY EBITDA Growth for the fiscal year that ended in Dec. 2019 is calculated as:

YoY EBITDA Growth (A: Dec. 2019 )
=(EBITDA per Share (A: Dec. 2019 )-EBITDA per Share (A: Dec. 2018 ))/ | EBITDA per Share (A: Dec. 2018 ) |
=(-0.231--0.459)/ | -0.459 |
=49.67 %

Registered Plan Private Investments's YoY EBITDA Growth for the quarter that ended in Dec. 2019 is calculated as:

YoY EBITDA Growth (Q: Dec. 2019 )
=(EBITDA per Share (Q: Dec. 2019 )-EBITDA per Share (Q: Dec. 2018 )) / | EBITDA per Share (Q: Dec. 2018 )) |
=(-0.144--0.049)/ | -0.049 |
=-193.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Registered Plan Private Investments YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Registered Plan Private Investments's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Registered Plan Private Investments (Registered Plan Private Investments) Business Description

Traded in Other Exchanges
N/A
Address
1055 West Hastings Street, Suite 1900, Vancouver, BC, CAN, V6E 2E9
Registered Plan Private Investments Inc is a private investment platform company that allows investors to use their Registered Plans (including registered retirement savings plans, registered education savings plans, tax-free savings accounts, registered retirement income funds, and registered disability savings plans) at their direction to invest in private companies by purchasing tracking shares in RPPI, which in turn uses these proceeds to invest in the specific private company chosen by the investor.

Registered Plan Private Investments (Registered Plan Private Investments) Headlines

From GuruFocus

Lexington Announces First Multicenter Clinical Study Site

By Marketwired Marketwired 08-21-2018

Lexington Biosciences Announces Results of Annual General Meeting

By Marketwired Marketwired 07-03-2018

Lexington Releases Audited Consolidated Financial Statements

By Marketwired Marketwired 05-01-2018

Lexington Biosciences Provides Update on Financial Situation

By Marketwired Marketwired 04-02-2019

Lexington Provides Q3 Corporate Review

By Marketwired Marketwired 10-24-2018

Lexington Biosciences Receives HeartSentry USPTO Patent Approval

By Marketwired Marketwired 07-25-2018

Lexington Biosciences Announces Termination of Private Placement

By Marketwired Marketwired 02-15-2019